[1] Ruan, W., Engevik, M.A., Spinler, J.K., et al., Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration. Digestive Diseases and Sciences, 2020. 65(3), 695-705.
[2] Rinninella E., Raoul P., Cintoni M., et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 2019. 7(1), 14. doi: 10.3390/microorganisms7010014
[3] Mosca, A., Leclerc, M., Hugot, J.P. Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Frontiers in Microbioliology, 2016. 7, 455. DOI: 10.3389/fmicb.2016.00455
[4] Bao, L., Zhang, Y., Zhang, G., et al., Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes. Communications Biology, 2023. 6, 226. doi: 10.1038/s42003-023-04591-x
[5] Xu, H., Liu, M., Cao, J.,et al. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. Journal of Immunology Research, 2019. 7546047. doi: 10.1155/2019/7546047.
[6] Vemuri R., Gundamaraju R., Shastri M.D., et al. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective. Biomed Research International, 2018. 4178607. doi: 10.1155/2018/4178607
[7] Maslowski, K.M., Mackay, C.R. Diet, gut microbiota and immune responses. Nature Immunology, 2011. 12(1), 5-9. https://doi.org/10.1038/ni0111-5
[8] Sonnenburg, J.L., Bäckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature, 2016. 535(7610), 56-64.v
[9] Scheppach, W. Effects of short chain fatty acids on gut morphology and function. Gut, 1994. 35(1 Suppl), S35-38.
DOI: 10.1136/gut.35.1_suppl.s35
[10] Gerritsen, J., et al. Intestinal microbiota in human health and disease: the
impact of probiotics. Genes & Nutrition, 2011. 6(3), 209-40. DOI: 10.1007/s12263-011-0229-7
[11] Macfarlane, G.T., Macfarlane, S. Bacteria, colonic fermentation, and gastrointestinal health. Journal of AOAC International, 2012. 95(1), 50-60. DOI: 10.5740/jaoacint.sge_macfarlane
[12] Koh, A., De Vadder, F., Kovatcheva-Datchary, P., et al. From Dietary Fiber to Host Physiology: Short Chain Fatty Acids as Key Bacterial Metabolites. Cell, 2016. 165(6):1332-1345. doi: 10.1016/j.cell.2016.05.041.
[13] EFSA, Scientific Opinion on the substantiation of health claims related to vitamin K and maintenance of bones (ID 123, 127, 128 and 2879), blood coagulation (ID 124 and 126), and function of the heart and blood vessels (ID 124, 125 and 2880) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal, 2009. 7(9), 1228. DOI:
[14] EFSA, Scientific Opinion on substantiation of health claims related to pantothenic acid and energy-yielding metabolism (ID 56, 59, 60, 64, 171, 172, 208), mental performance (ID 57), maintenance of bone (ID 61), maintenance of teeth (ID 61), maintenance of hair (ID 61), maintenance of skin (ID 61), maintenance of nails (ID 61) and synthesis and metabolism of steroid hormones, vitamin D and some neurotransmitters (ID 181) pursuant to Article 13 of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9):1218.
[15] EFSA, Scientific Opinion on the substantiation of health claims related to pantothenic acid and mental performance (ID 58), reduction of tiredness and fatigue (ID 63), adrenal function (ID 204) and maintenance of normal skin (ID 2878) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010. 8(10), 1758.
[16] EFSA, Scientific opinion on the substantiation of health claims related to biotin and energy-yielding metabolism (ID 114, 117), macronutrient metabolism (ID 113, 114, 117), maintenance of skin and mucous membranes (ID 115), maintenance of hair (ID 118, 2876) and function of the nervous system (ID 116) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal, 2009. 7(9),1209.v
[17] EFSA, Scientific Opinion on the substantiation of health claims related to biotin and maintenance of normal skin and mucous membranes (ID 121), maintenance of normal hair (ID 121), maintenance of normal bone (ID 121), maintenance of normal teeth (ID 121), maintenance of normal nails (ID 121, 2877), reduction of tiredness and fatigue (ID 119), contribution to normal psychological functions (ID 120) and contribution to normal macronutrient metabolism (ID 4661) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010; 8(10):1728.
[18] EFSA, Scientific Opinion on the substantiation of health claims related to folate and contribution to normal psychological functions (ID 81, 85, 86, 88), maintenance of normal vision (ID 83, 87), reduction of tiredness and fatigue (ID 84), cell division (ID 195, 2881) and contribution to normal amino acid synthesis (ID 195, 2881) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010. 8(10),1760.
[19] EFSA, Scientific opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal, 2009. 7(9), 1223.
[20] EFSA, Scientific Opinion on the substantiation of health claims related to vitamin B12 and contribution to normal neurological and psychological functions (ID 95, 97, 98, 100, 102, 109), contribution to normal homocysteine metabolism (ID 96, 103, 106), maintenance of normal bone (ID 104), maintenance of normal teeth (ID 104), maintenance of normal hair (ID 104), maintenance of normal skin (ID 104), maintenance of normal nails (ID 104), reduction of tiredness and fatigue (ID 108), and cell division (ID 212) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010. 8(10),1756.
[21] Duranti, S., Ruiz, L., Lugli, G.A., et al. Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA. Scientific Reports, 2020. 10, 14112. DOI: 10.1038/s41598-020-70986-z
[22] Strandwitz, P. Neurotransmitter modulation by the gut microbiota. Brain Research, 2018. 1693(Pt B),128-133.
[23] Ubeda, C., Djukovic, A., Isaac, S. Roles of the intestinal microbiota in pathogen protection. Clinical & Translational Immunology, 2017. 6(2), e128.
[24] Petersen, C., Round, J.L. Defining dysbiosis and its influence on host immunity and disease. Cellular Microbiology, 2014. 16(7), 1024-33. DOI: 10.1111/cmi.12308
[25] Ducarmon, Q.R., Zwittink, R.D., Hornung, B.V.H., et al. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection. Microbiology and Molecular Biology Reviews, 2019. 83(3), e00007-19. DOI: 10.1128/MMBR.00007-19
[26] Gerritsen, J., Smidt, H., Rijkers, G.T., et al. Intestinal microbiota in human health and disease: the impact of probiotics. Genes & Nutrition, 2011. 6(3), 209-40. doi: 10.1007/s12263-011-0229-7
[27] Hill, C., Guarner, F., Reid, G., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 2014. 11(8), 506-14. doi: 10.1038/nrgastro.2014.66
[28] Gibson, G.R., Hutkins, R., Sanders, M.E., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 2017. 14(8), 491-502. doi: 10.1038/nrgastro.2017.75
[29] Gibson, G.R., Roberfroid, M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition, 1995. 125(6), 1401-12. doi: 10.1093/jn/125.6.1401
[30] Wopereis, H., Oozeer, R., Knipping, K., et al. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatric Allergy & Immunology, 2014. 25(5), 428-38. doi: 10.1111/pai.12232
[31] Martin, R., Nauta, A.J., Ben Amor, K., et al. Early life: gut microbiota and immune development in infancy. Beneficial Microbes, 2010. 1(4), 367-82. doi: 10.3920/BM2010.0027
[32] Leeuwendaal NK, Stanton C, O'Toole PW, Beresford TP. Fermented Foods, Health and the Gut Microbiome. Nutrients. 2022 Apr 6;14(7):1527. doi: 10.3390/nu14071527.
[33] Eales J., et al. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2016. First published on October 9, 2016.
[34] Agrawal A, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114.